Lon Cardon

CIK: 0001854337

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)2 (33.3%)

Derivative conversions

Awards (A)4 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

MIRM

Mirum Pharmaceuticals, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (6 total)

MIRM
Mirum Pharmaceuticals, Inc.
Jun 15, 2026
Award(A)
Stock Option (right to buy)
Direct
3.8K shares-
MIRM
Mirum Pharmaceuticals, Inc.
Jun 15, 2026
Award(A)
Restricted Stock Units
Direct
2K shares-
MIRM
Mirum Pharmaceuticals, Inc.
May 29, 2026
Exercise(M)
Direct
4K shares-
MIRM
Mirum Pharmaceuticals, Inc.
May 29, 2025
Exercise(M)
Direct
5.7K shares-
MIRM
Mirum Pharmaceuticals, Inc.
May 29, 2025
Award(A)
Stock Option (right to buy)
Direct
6.3K shares-
MIRM
Mirum Pharmaceuticals, Inc.
May 29, 2025
Award(A)
Restricted Stock Units
Direct
4K shares-

		Type	Shares	Price		Ownership
Jun 15, 2026	MIRM Mirum Pharmaceuticals, Inc.	Award(A) Stock Option (right to buy)	3,772	-	-	Direct
Jun 15, 2026	MIRM Mirum Pharmaceuticals, Inc.	Award(A) Restricted Stock Units	1,980	-	-	Direct
May 29, 2026	MIRM Mirum Pharmaceuticals, Inc.	Exercise(M)	3,977	-	$0	Direct
May 29, 2025	MIRM Mirum Pharmaceuticals, Inc.	Exercise(M)	5,703	-	-	Direct
May 29, 2025	MIRM Mirum Pharmaceuticals, Inc.	Award(A) Stock Option (right to buy)	6,268	-	-	Direct
May 29, 2025	MIRM Mirum Pharmaceuticals, Inc.	Award(A) Restricted Stock Units	3,977	-	-	Direct

1-6 of 6 transactions

About Cardon Lon

Cardon Lon (SEC CIK 0001854337) files insider reports with the SEC as Director of Mirum Pharmaceuticals, Inc. (MIRM).

Signal8 holds 3 ownership filings by Cardon Lon, all Form 4s, filed between Jun 2, 2025 and Jun 17, 2026. Those filings report 6 transactions, from May 29, 2025 to Jun 15, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Cardon Lon's filings is in FOSTER CITY, CA.

Recent filings by Cardon Lon

Jun 15, 2026: Grants or awards of MIRM derivative securities (2 lines, Form 4, code A).
May 29, 2026: Option exercise of MIRM shares (Form 4, code M).
May 29, 2025: Option exercise of MIRM shares (Form 4, code M).
May 29, 2025: Grants or awards of MIRM derivative securities (2 lines, Form 4, code A).

Other insiders filing for Mirum Pharmaceuticals, Inc. (MIRM)

Howe Jolanda, SVP, GLOBAL CONTROLLER
Myers Robert Paul, Chief Medical Officer
Peetz Christopher, CHIEF EXECUTIVE OFFICER
BJERKHOLT ERIC, CHIEF FINANCIAL OFFICER
Walbert Timothy P, Director
Ramasastry Saira, Director

How to read Form 4 transaction codes